Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension

  Free Subscription


04.02.2019

1 Adv Exp Med Biol
1 Am J Health Syst Pharm
1 Am J Physiol Heart Circ Physiol
1 Anatol J Cardiol
1 Ann Cardiol Angeiol (Paris)
1 Ann Hematol
1 Arch Med Sci
1 Bratisl Lek Listy
1 Cardiol Young
1 Cardiovasc Pathol
3 Clin Exp Rheumatol
1 Cochrane Database Syst Rev
1 Drug Res (Stuttg)
1 ESC Heart Fail
1 Eur Respir J
1 Exp Ther Med
1 Expert Opin Pharmacother
1 Expert Rev Cardiovasc Ther
1 Front Cardiovasc Med
1 Heart
1 Heart Lung
1 Heart Lung Circ
2 Int J Cardiol
1 Int J Cardiovasc Imaging
1 Int J Mol Sci
1 J Cardiothorac Vasc Anesth
1 J Clin Ultrasound
1 J Korean Med Sci
1 Klin Lab Diagn
1 Mol Med Rep
1 Pharmacol Res Perspect
2 Pulm Circ
1 Rev Mal Respir
1 Rev Med Liege
3 Ter Arkh
1 Transplantation
1 Zhonghua Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Exp Med Biol

  1. CICCO S, Leone P, Racanelli V, Vacca A, et al
    Mucine-1 Is Related to Cell-Mediated Immunoexpression and Blood Pressure in Pulmonary Artery in Pulmonary Arterial Hypertension (PAH): Preliminary Results.
    Adv Exp Med Biol. 2018;1072:275-280.
    PubMed     Text format     Abstract available


    Am J Health Syst Pharm

  2. SMITH ZR, Rangarajan K, Barrow J, Carter D, et al
    Development of best practice recommendations for the safe use of pulmonary hypertension pharmacotherapies using a modified Delphi method.
    Am J Health Syst Pharm. 2019;76:153-165.
    PubMed     Text format     Abstract available


    Am J Physiol Heart Circ Physiol

  3. SU J, Logan CC, Hughes AD, Parker KH, et al
    Impact of chronic hypoxia on proximal pulmonary artery wave propagation and mechanical properties in rats.
    Am J Physiol Heart Circ Physiol. 2018;314:H1264-H1278.
    PubMed     Text format     Abstract available


    Anatol J Cardiol

  4. KALANTARI KR, Malek H, Amin A, Moosavi J, et al
    Chronic thromboembolic pulmonary hypertension versus fibrosing mediastinitis.
    Anatol J Cardiol. 2019;21:E4-E5.
    PubMed     Text format    


    Ann Cardiol Angeiol (Paris)

  5. RACHDI I, Tougorti M, Daoud F, Aydi Z, et al
    Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
    Ann Cardiol Angeiol (Paris). 2019 Jan 23. pii: S0003-3928(18)30201.
    PubMed     Text format     Abstract available


    Ann Hematol

  6. MANAKENG K, Prasertphol P, Phongpao K, Chuncharunee S, et al
    Elevated levels of platelet- and red cell-derived extracellular vesicles in transfusion-dependent beta-thalassemia/HbE patients with pulmonary arterial hypertension.
    Ann Hematol. 2019;98:281-288.
    PubMed     Text format     Abstract available


    Arch Med Sci

  7. MEHRA P, Mehta V, Sukhija R, Sinha AK, et al
    Pulmonary hypertension in left heart disease.
    Arch Med Sci. 2019;15:262-273.
    PubMed     Text format    


    Bratisl Lek Listy

  8. BACIK P, Poliacikova P, Kaliska G
    Who needs a permanent pacemaker after transcatheter aortic valve implantation?
    Bratisl Lek Listy. 2018;119:560-565.
    PubMed     Text format     Abstract available


    Cardiol Young

  9. AGGARWAL M, Schuettpelz L, Kolodziej J, Grady RM, et al
    Rapid development of pulmonary hypertension during treatment of paediatric cancer.
    Cardiol Young. 2019 Jan 25:1-4. doi: 10.1017/S1047951118002196.
    PubMed     Text format     Abstract available


    Cardiovasc Pathol

  10. YUE Y, Zhang Z, Zhang L, Chen S, et al
    miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Cardiovasc Pathol. 2018;37:15-25.
    PubMed     Text format     Abstract available


    Clin Exp Rheumatol

  11. VANDECASTEELE E, Melsens K, De Keyser F, De Pauw M, et al
    A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
    Clin Exp Rheumatol. 2018;36 Suppl 113:95-101.
    PubMed     Text format     Abstract available

  12. LUPPINO ASSAD AP, Gavilanes Oleas F, Alves JL Jr, Dos Santos Fernandes CJC, et al
    Survival of connective tissue disease associated pulmonary arterial hypertension.
    Clin Exp Rheumatol. 2018;36 Suppl 113:186.
    PubMed     Text format    

  13. RIZZI M, Radovanovic D, Santus P, Airoldi A, et al
    Usefulness of six-minute walk test in systemic sclerosis.
    Clin Exp Rheumatol. 2018;36 Suppl 113:161-167.
    PubMed     Text format     Abstract available


    Cochrane Database Syst Rev

  14. BARNES H, Brown Z, Burns A, Williams T, et al
    Phosphodiesterase 5 inhibitors for pulmonary hypertension.
    Cochrane Database Syst Rev. 2019;1:CD012621.
    PubMed     Text format     Abstract available


    Drug Res (Stuttg)

  15. LEIFER FG, Konicek DM, Chen KJ, Plaunt AJ, et al
    Inhaled Treprostinil-Prodrug Lipid Nanoparticle Formulations Provide Long-Acting Pulmonary Vasodilation.
    Drug Res (Stuttg). 2018;68:605-614.
    PubMed     Text format     Abstract available


    ESC Heart Fail

  16. YOSHIHISA A, Yokokawa T, Misaka T, Oikawa M, et al
    Soluble neprilysin does not correlate with prognosis in pulmonary hypertension.
    ESC Heart Fail. 2019 Jan 25. doi: 10.1002/ehf2.12404.
    PubMed     Text format     Abstract available


    Eur Respir J

  17. HOEPER MM, Boucly A, Sitbon O
    Age, risk and outcomes in idiopathic pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    Exp Ther Med

  18. ZHAO J, Yang M, Wu X, Yang Z, et al
    Effects of paclitaxel intervention on pulmonary vascular remodeling in rats with pulmonary hypertension.
    Exp Ther Med. 2019;17:1163-1170.
    PubMed     Text format     Abstract available


    Expert Opin Pharmacother

  19. JOYCE KE, Lucas SJE, Imray CHE, Balanos GM, et al
    Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema.
    Expert Opin Pharmacother. 2018;19:1891-1902.
    PubMed     Text format     Abstract available


    Expert Rev Cardiovasc Ther

  20. NTILOUDI D, Zanos S, Gatzoulis MA, Karvounis H, et al
    How to evaluate patients with congenital heart disease-related pulmonary arterial hypertension.
    Expert Rev Cardiovasc Ther. 2019;17:11-18.
    PubMed     Text format     Abstract available


    Front Cardiovasc Med

  21. MULCHRONE A, Kellihan HB, Forouzan O, Hacker TA, et al
    A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function.
    Front Cardiovasc Med. 2019;5:189.
    PubMed     Text format     Abstract available


    Heart

  22. SKORO-SAJER N, Gerges C, Balint OH, Kohalmi D, et al
    Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension.
    Heart. 2018;104:1195-1199.
    PubMed     Text format     Abstract available


    Heart Lung

  23. WALIGORA M, Tyrka A, Miszalski-Jamka T, Urbanczyk-Zawadzka M, et al
    Right atrium enlargement predicts clinically significant supraventricular arrhythmia in patients with pulmonary arterial hypertension.
    Heart Lung. 2018;47:237-242.
    PubMed     Text format     Abstract available


    Heart Lung Circ

  24. ARVANITAKI A, Mouratoglou SA, Evangeliou A, Grosomanidis V, et al
    Quality of Life is Related to Haemodynamics in Precapillary Pulmonary Hypertension.
    Heart Lung Circ. 2019 Jan 15. pii: S1443-9506(19)30025.
    PubMed     Text format     Abstract available


    Int J Cardiol

  25. TELLO K, Axmann J, Ghofrani HA, Naeije R, et al
    Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension.
    Int J Cardiol. 2018;266:229-235.
    PubMed     Text format     Abstract available

  26. CHEN F, Wang H, Lai J, Cai S, et al
    3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: In vitro and in vivo studies.
    Int J Cardiol. 2018;266:236-241.
    PubMed     Text format     Abstract available


    Int J Cardiovasc Imaging

  27. HABASH S, Laser KT, Moosmann J, Reif R, et al
    Normal values of the pulmonary artery acceleration time (PAAT) and the right ventricular ejection time (RVET) in children and adolescents and the impact of the PAAT/RVET-index in the assessment of pulmonary hypertension.
    Int J Cardiovasc Imaging. 2019 Jan 28. pii: 10.1007/s10554-019-01540.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  28. VORSELAARS VMM, Hosman AE, Westermann CJJ, Snijder RJ, et al
    Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available


    J Cardiothorac Vasc Anesth

  29. RAM E, Sternik L, Klempfner R, Eldar M, et al
    Sildenafil for Pulmonary Hypertension in the Early Postoperative Period After Mitral Valve Surgery.
    J Cardiothorac Vasc Anesth. 2018 Dec 25. pii: S1053-0770(18)31180.
    PubMed     Text format     Abstract available


    J Clin Ultrasound

  30. GHAEMIAN A, Nabati M, Dabirian M, Shokri M, et al
    Isolated partial right lower lobe pulmonary venous drainage into the right atrium as a cause of pulmonary hypertension in a middle-aged woman.
    J Clin Ultrasound. 2019 Jan 25. doi: 10.1002/jcu.22691.
    PubMed     Text format     Abstract available


    J Korean Med Sci

  31. CHOI S, Park SI, Lee GD, Kim HR, et al
    The First Living-Donor Lobar Lung Transplantation in Korea: a Case Report.
    J Korean Med Sci. 2018;33:e282.
    PubMed     Text format     Abstract available


    Klin Lab Diagn

  32. AVDEEV SN, Gaynitdinova VV, Tsareva NA, Merzhoeva ZM, et al
    [Natriuretic peptides as markers of development and prognosis of pulmonary hypertension severity in patients with chronic obstructive disease.]
    Klin Lab Diagn. 2018;63:333-337.
    PubMed     Text format     Abstract available


    Mol Med Rep

  33. ZHU G, Zhang W, Liu Y, Wang S, et al
    miR371b5p inhibits endothelial cell apoptosis in monocrotalineinduced pulmonary arterial hypertension via PTEN/PI3K/Akt signaling pathways.
    Mol Med Rep. 2018;18:5489-5501.
    PubMed     Text format     Abstract available


    Pharmacol Res Perspect

  34. NILSSON KF, Gustafsson LE
    Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism.
    Pharmacol Res Perspect. 2019;7:e00462.
    PubMed     Text format     Abstract available


    Pulm Circ

  35. AKAGI S, Ejiri K, Kasahara S, Nakamura K, et al
    EXPRESS: Improvement of Lung Function and Pulmonary Hypertension After Pulmonary Aneurysm Repair: Case Series.
    Pulm Circ. 2019 Jan 30:2045894019831217. doi: 10.1177/2045894019831217.
    PubMed     Text format    

  36. VULLAGANTI S, Tibrewala A, Rich J, Pham DT, et al
    EXPRESS: The use of a durable right ventricular assist device for isolated right ventricular failure due to combined pre- and postcapillary pulmonary hypertension.
    Pulm Circ. 2019 Jan 30:2045894019831222. doi: 10.1177/2045894019831222.
    PubMed     Text format    


    Rev Mal Respir

  37. CHAOUAT A, Cherifi A, Sitbon O, Girerd N, et al
    [Evaluation of cardiac MRI in the follow up assessment of patients with pulmonary arterial hypertension].
    Rev Mal Respir. 2018;35:749-758.
    PubMed     Text format     Abstract available


    Rev Med Liege

  38. ASTADICKO I, Dresse MF, Seghaye MC
    [Cardiac complications of sickle cell disease in children].
    Rev Med Liege. 2018;73:550-556.
    PubMed     Text format     Abstract available


    Ter Arkh

  39. CHAZOVA IE, Martynyuk TV, Valieva ZS, Nakonechnikov SN, et al
    The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.
    Ter Arkh. 2018;90:101-109.
    PubMed     Text format     Abstract available

  40. VALIEVA ZS, Taran IN, Martynyuk TV, Chazova IY, et al
    Modern view on the place of riociguat in the treatment of pulmonary hypertension.
    Ter Arkh. 2018;90:55-59.
    PubMed     Text format     Abstract available

  41. MARTYNYUK TV, Nakonechnikov SN, Chazova IY
    New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension.
    Ter Arkh. 2018;90:72-80.
    PubMed     Text format     Abstract available


    Transplantation

  42. VIONNET J, Yerly P, Aubert JD, Pascual M, et al
    Management of severe portopulmonary hypertension with dual oral therapy prior to liver transplantation.
    Transplantation. 2018 Feb 26. doi: 10.1097/TP.0000000000002142.
    PubMed     Text format    


    Zhonghua Yi Xue Za Zhi

  43. RUAN HY, Zhang YG, Liu R
    [Acute effects of intravenous fasudil with different dosage on patients with congenital heart defects and severe pulmonary arterial hypertension].
    Zhonghua Yi Xue Za Zhi. 2018;98:678-681.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: